20 Jul 2020
// MOLECULARPARTNERS
https://www.molecularpartners.com/molecular-partners-provides-regulatory-update-of-european-and-japanese-filings-of-abicipar-pegol/
29 Jun 2020
// EYEWIRE
https://eyewire.news/articles/allergan-and-molecular-partners-receive-complete-response-letter-from-fda-on-biologics-license-application-for-abicipar-pegol/
26 Jun 2020
// John Miller REUTERS
https://uk.reuters.com/article/us-molecular-prtnrs-abbvie-eye-drug/molecular-partnerss-abbvie-partnered-eye-drug-gets-fda-safety-snub-idUKKBN23X0WG
26 Jun 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/allergan-an-abbvie-company-and-molecular-partners-receive-complete-response-letter-from-fda-on-biologics-license-application-for-abicipar-pegol-301084188.html
15 Oct 2019
// BIOSPACE
https://www.biospace.com/article/releases/allergan-and-molecular-partners-present-late-breaking-data-from-phase-3-studies-of-investigational-abicipar-pegol-in-neovascular-wet-age-related-macular-degeneration/?s=95
02 Apr 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/allergan-and-molecular-partners-announce-topline-safety-results-from-maple-study-of-abicipar-pegol-300822353.html
LOOKING FOR A SUPPLIER?